ArticlePharmacoEconomics - open2021

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.

Christine M Cramer-van der Welle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.